{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:09:52Z","timestamp":1792840192572,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.taap.2024.116825","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T23:50:45Z","timestamp":1705794645000},"page":"116825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Anti-NOTCH1 therapy with OMP-52\u00a0M51 inhibits salivary adenoid cystic carcinoma by depressing epithelial-mesenchymal transition (EMT) process and inducing ferroptosis"],"prefix":"10.1016","volume":"484","author":[{"given":"Ran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanxin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.taap.2024.116825_bb0005","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/sctm.16-0335","article-title":"Gamma-secretase inhibitor IX (GSI) impairs concomitant activation of notch and wnt-beta-catenin pathways in CD44+ gastric cancer stem cells","volume":"6","author":"Barat","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"115","key":"10.1016\/j.taap.2024.116825_bb0010","first-page":"189","article-title":"Notch\u2014a goldilocks signaling pathway in disease and cancer therapy","volume":"21","author":"Braune","year":"2016","journal-title":"Discov. Med."},{"key":"10.1016\/j.taap.2024.116825_bb0015","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.taap.2024.116825_bb0020","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/carcin\/bgt127","article-title":"The notch signaling pathway as a mediator of tumor survival","volume":"34","author":"Capaccione","year":"2013","journal-title":"Carcinogenesis"},{"issue":"22","key":"10.1016\/j.taap.2024.116825_bb0025","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1182\/blood.V128.22.5108.5108","article-title":"Safety and preliminary efficacy results of a phase I first-in-human study of the novel Notch-1 targeting antibody brontictuzumab (OMP-52M51) administered intravenously to patients with hematologic malignancies","volume":"128","author":"Casulo","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.taap.2024.116825_bb0030","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.bbagen.2014.08.005","article-title":"Deregulation of Bmi-1 is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma","volume":"1840","author":"Chang","year":"2014","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.taap.2024.116825_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.artmed.2017.02.001","article-title":"Analysis of cancer-related lncRNAs using gene ontology and KEGG pathways","volume":"76","author":"Chen","year":"2017","journal-title":"Artif. Intell. Med."},{"key":"10.1016\/j.taap.2024.116825_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.artmed.2017.02.001","article-title":"Analysis of cancer-related lncRNAs using gene ontology and KEGG pathways","volume":"76","author":"Chen","year":"2017","journal-title":"Artif. Intell. Med."},{"issue":"7","key":"10.1016\/j.taap.2024.116825_bb0045","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.oraloncology.2015.04.005","article-title":"Adenoid cystic carcinoma of the head and neck-an update","volume":"51","author":"Coca-Pelaz","year":"2015","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.taap.2024.116825_bb0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2015.03.005","article-title":"A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: a study of the Princess Margaret, Chicago and California phase II consortia","volume":"137","author":"Diaz-Padilla","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.taap.2024.116825_bb0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10637-019-00739-x","article-title":"Safety and clinical activity of the notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma","volume":"38","author":"Even","year":"2020","journal-title":"Investig. New Drugs"},{"issue":"3","key":"10.1016\/j.taap.2024.116825_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/JCO.2016.67.5264","article-title":"Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors","volume":"35","author":"Ferrarotto","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.taap.2024.116825_bb0065","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/annonc\/mdy171","article-title":"A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors","volume":"29","author":"Ferrarotto","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2024.116825_bb0070","doi-asserted-by":"crossref","first-page":"S663","DOI":"10.1016\/j.annonc.2020.08.1034","article-title":"919MO ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent\/metastatic (R\/M) adenoid cystic carcinoma (ACC) harboring notch activating mutations (Notchmut)","volume":"31","author":"Ferrarotto","year":"2020","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.taap.2024.116825_bb0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41419-022-05133-9","article-title":"AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling","volume":"13","author":"Ferrarotto","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.taap.2024.116825_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5925-5","article-title":"NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12\/CXCR4 pathway","volume":"19","author":"Gao","year":"2019","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.taap.2024.116825_bb0085","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/s41418-022-01003-1","article-title":"Selective ferroptosis vulnerability due to familial Alzheimer\u2019s disease presenilin mutations","volume":"29","author":"Greenough","year":"2022","journal-title":"Cell Death Differ."},{"issue":"12","key":"10.1016\/j.taap.2024.116825_bb0090","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1365-2591.2012.02079.x","article-title":"Multiple osteolytic lesions of intraosseous adenoid cystic carcinoma in the mandible mimicking apical periodontitis","volume":"45","author":"Grimm","year":"2012","journal-title":"Int. Endod. J."},{"issue":"3","key":"10.1016\/j.taap.2024.116825_bb0095","first-page":"671","article-title":"Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma","volume":"23","author":"Gu","year":"2010","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.taap.2024.116825_bb0100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/onc.2011.265","article-title":"Neutralization of the \u03b3-secretase activity by monoclonal antibody against extracellular domain of nicastrin","volume":"31","author":"Hayashi","year":"2012","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.taap.2024.116825_bb0105","doi-asserted-by":"crossref","DOI":"10.1242\/dev.172148","article-title":"Mechanisms of notch signaling: a simple logic deployed in time and space","volume":"146","author":"Henrique","year":"2019","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.taap.2024.116825_bb0110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.oraloncology.2008.04.009","article-title":"Epiregulin promotes migration and invasion of salivary adenoid cystic carcinoma cell line SACC-83 through activation of ERK and Akt[J]","volume":"45","author":"Hu","year":"2009","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.taap.2024.116825_bb0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.oraloncology.2014.10.008","article-title":"BDNF mediated TrkB activation contributes to the EMT progression and the poor prognosis in human salivary adenoid cystic carcinoma","volume":"51","author":"Jia","year":"2015","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.taap.2024.116825_bb0120","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/ncomms4838","article-title":"Cathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia","volume":"5","author":"Jiang","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.taap.2024.116825_bb0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/1535-7163.MCT-09-0771","article-title":"Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis","volume":"9","author":"Koduru","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.taap.2024.116825_bb0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1634\/theoncologist.12-5-535","article-title":"Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors","volume":"12","author":"Kunnimalaiyaan","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.taap.2024.116825_bb0135","article-title":"Induction of ferroptosis in head and neck cancer: a novel bridgehead for fighting cancer resilience","author":"Lee","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2024.116825_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-017-1039-6","article-title":"Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy","volume":"34","author":"Li","year":"2017","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.taap.2024.116825_bb0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.taap.2024.116825_bb0150","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/2211-5463.13393","article-title":"Notch3 regulates ferroptosis via ROS-induced lipid peroxidation in NSCLC cells","volume":"12","author":"Li","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.taap.2024.116825_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102435","article-title":"Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation","volume":"56","author":"Li","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.taap.2024.116825_bb0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/leu.2014.143","article-title":"The \u03b3-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells","volume":"29","author":"L\u00f3pez-Guerra","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.taap.2024.116825_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105213","article-title":"Prognosis and management of recurrent and\/or metastatic head and neck adenoid cystic carcinoma","volume":"115","author":"Lorini","year":"2021","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.taap.2024.116825_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41573-020-00091-3","article-title":"Targeting notch in oncology: the path forward","volume":"20","author":"Majumder","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2024.116825_bb0175","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.2147\/IJGM.S343948","article-title":"Bioinformatic analysis of prognostic value, genetic interaction, and immune infiltration of chromobox family proteins in breast cancer","author":"Mao","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"1","key":"10.1016\/j.taap.2024.116825_bb0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1158\/1078-0432.CCR-14-0607","article-title":"A phase I, dose-finding study in patients with advanced solid malignancies of the oral \u03b3-secretase inhibitor PF-03084014\u03b3-secretase inhibitor PF-03084014 evaluation in solid tumors","volume":"21","author":"Messersmith","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.taap.2024.116825_bb0185","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-17-0058","article-title":"Synergistic activity with NOTCH inhibition and androgen ablation in ERG-positive prostate cancer cells","volume":"15","author":"Mohamed","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.taap.2024.116825_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12105-013-0426-3","article-title":"Adenoid cystic carcinoma: clinical and molecular features","volume":"7","author":"Moskaluk","year":"2013","journal-title":"Head Neck Pathol."},{"issue":"4","key":"10.1016\/j.taap.2024.116825_bb0195","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2018.01.002","article-title":"Dynamic ligand discrimination in the notch signaling pathway","volume":"172","author":"Nandagopal","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.taap.2024.116825_bb0200","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/s41467-017-01500-9","article-title":"Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma","volume":"8","author":"Natsuizaka","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2024.116825_bb0205","first-page":"943","article-title":"Gamma secretase inhibitors of notch signaling","author":"Olsauskas-Kuprys","year":"2013","journal-title":"Onco Targets Ther"},{"issue":"8","key":"10.1016\/j.taap.2024.116825_bb0210","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1158\/1078-0432.CCR-15-2208","article-title":"NOTCH1 and SOX10 are essential for proliferation and radiation resistance of cancer stem\u2013like cells in adenoid cystic carcinoma","volume":"22","author":"Panaccione","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.taap.2024.116825_bb0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.canlet.2012.09.023","article-title":"Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells","volume":"328","author":"Qiu","year":"2013","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.taap.2024.116825_bb0220","first-page":"4092","article-title":"Systemic therapies for salivary gland adenoid cystic carcinoma","volume":"11","author":"Sahara","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"12","key":"10.1016\/j.taap.2024.116825_bb0225","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3390\/cells9122677","article-title":"NOTCH1 signaling in head and neck squamous cell carcinoma","volume":"9","author":"Shah","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.taap.2024.116825_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.652273","article-title":"Biological significance of NOTCH signaling strength","volume":"9","author":"Shen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"16","key":"10.1016\/j.taap.2024.116825_bb0235","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.18632\/oncotarget.2321","article-title":"NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma","volume":"5","author":"Su","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2024.116825_bb0240","series-title":"CRISPR\/Cas9 Screening Reveals that ASB2 Inhibits p53-Dependent Ferroptosis to Mediates Lenvatinib Resistance in Hepatocellular Carcinoma","author":"Sun","year":"2023"},{"issue":"2","key":"10.1016\/j.taap.2024.116825_bb0245","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pharmthera.2013.09.005","article-title":"Targeting notch signaling pathway in cancer: clinical development advances and challenges","volume":"141","author":"Takebe","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.taap.2024.116825_bb0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lungcan.2014.05.001","article-title":"Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma","volume":"85","author":"Wael","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.taap.2024.116825_bb0255","article-title":"B-cell specific Moloney murine leukemia virus insertion site 1 contributes to invasion, metastasis, and poor prognosis in salivary adenoid cystic carcinoma","author":"Wang","year":"2023","journal-title":"J. Dent. Sci."},{"issue":"8","key":"10.1016\/j.taap.2024.116825_bb0260","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1158\/1535-7163.MCT-17-0001","article-title":"Notch inhibitor PF-03084014 inhibits hepatocellular carcinoma growth and metastasis via suppression of cancer stemness due to reduced activation of Notch1\u2013Stat3","volume":"16","author":"Wu","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2024.116825_bb0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2018.04.020","article-title":"Alterations of notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival","volume":"121","author":"Xie","year":"2018","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.taap.2024.116825_bb0270","doi-asserted-by":"crossref","first-page":"598","DOI":"10.7150\/ijbs.36407","article-title":"The NOTCH1-HEY1 pathway regulates self-renewal and epithelial-mesenchymal transition of salivary adenoid cystic carcinoma cells","volume":"16","author":"Xie","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.taap.2024.116825_bb0275","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"30","key":"10.1016\/j.taap.2024.116825_bb0280","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1016\/j.biomaterials.2014.06.040","article-title":"Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer","volume":"35","author":"Yallapu","year":"2014","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.taap.2024.116825_bb0285","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1601-0825.2006.01334.x","article-title":"\u03b3-secretase inhibitors exerts antitumor activity via down-regulation of notch and nuclear factor kappa B in human tongue carcinoma cells","volume":"13","author":"Yao","year":"2007","journal-title":"Oral Dis."},{"issue":"10","key":"10.1016\/j.taap.2024.116825_bb0290","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/labinvest.2013.95","article-title":"The pathological significance of Notch1 in oral squamous cell carcinoma","volume":"93","author":"Yoshida","year":"2013","journal-title":"Lab. Investig."},{"issue":"1","key":"10.1016\/j.taap.2024.116825_bb0295","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2015.07.048","article-title":"Notch signaling: an emerging therapeutic target for cancer treatment","volume":"369","author":"Yuan","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2024.116825_bb0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2020.01.039","article-title":"Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells","volume":"479","author":"Yusenko","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2024.116825_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.743006","article-title":"Molecular mechanisms of ferroptosis and its roles in hematologic malignancies","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.taap.2024.116825_bb0310","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ccell.2017.11.002","article-title":"Therapeutic antibody targeting tumor-and osteoblastic niche-derived Jagged1 sensitizes bone metastasis to chemotherapy","volume":"32","author":"Zheng","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.taap.2024.116825_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12739","article-title":"Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K\/AKT\/mTOR pathway","volume":"53","author":"Zhou","year":"2020","journal-title":"Cell Prolif."},{"issue":"8","key":"10.1016\/j.taap.2024.116825_bb0320","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41419-021-04039-2","article-title":"The requirement of mitochondrial RNA polymerase for non-small cell lung cancer cell growth","volume":"12","author":"Zhou","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.taap.2024.116825_bb0325","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1066896913496146","article-title":"Elevated expression of Notch1 is associated with metastasis of human malignancies","volume":"21","author":"Zhu","year":"2013","journal-title":"Int. J. Surg. Pathol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24000231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24000231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:05:08Z","timestamp":1758575108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24000231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":65,"alternative-id":["S0041008X24000231"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.116825","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-NOTCH1 therapy with OMP-52\u00a0M51 inhibits salivary adenoid cystic carcinoma by depressing epithelial-mesenchymal transition (EMT) process and inducing ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.116825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116825"}}